AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • October 30th, 2020 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 30th, 2020 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 22, 2020 and is entered into by and between Tammi Ranalli (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • October 30th, 2020 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 30th, 2020 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 22, 2020 and is entered into by and between William Ferenczy (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • May 9th, 2019 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 9th, 2019 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of __February 11___, 2019 and is entered into by and between Karen Gibson (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • February 27th, 2018 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 27th, 2018 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 16, 2017 and is entered into by and between Ratan S. Borkar (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • October 29th, 2015 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 29th, 2015 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 12, 2015 and is entered into by and between Edward Russell (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • April 24th, 2015 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 24th, 2015 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of January 19, 2015 and is entered into by and between Michael D. Abney, Jr. (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • July 24th, 2014 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJuly 24th, 2014 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of May 8, 2014 and is entered into by and between Werner Kroll (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • October 21st, 2011 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 21st, 2011 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of September 19, 2011 and is entered into by and between Randall J. Steward (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • August 3rd, 2011 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 3rd, 2011 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of May 11, 2011 and is entered into by and between Mark W. Smits (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • February 19th, 2010 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 19th, 2010 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of February 19, 2010 and is entered into by and between David Scholl (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • October 21st, 2009 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledOctober 21st, 2009 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of September 1, 2009 and is entered into by and between Timothy T. Stenzel (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • January 20th, 2009 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJanuary 20th, 2009 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of January 16, 2009 and is entered into by and between Douglas C. Bryant (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • November 7th, 2008 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledNovember 7th, 2008 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of November 7, 2008 and is entered into by and between John Tamerius (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • June 6th, 2008 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 6th, 2008 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of June 5, 2008 and is entered into by and between Robert Bujarski (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • June 26th, 2007 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 26th, 2007 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of June 25, 2007 and is entered into by and between Richard C. Tarbox III (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • June 26th, 2007 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 26th, 2007 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of June 25, 2007 and is entered into by and between Scot McLeod (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • February 20th, 2007 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 20th, 2007 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of February 14, 2007 and is entered into by and between Robert J. Bujarski (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • January 3rd, 2007 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJanuary 3rd, 2007 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of December 18, 2006 and is entered into by and between John M. Radak (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • June 17th, 2005 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledJune 17th, 2005 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of June 9, 2005 and is entered into by and between Robert J. Bujarski (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).
AGREEMENT RE: CHANGE IN CONTROLAgreement Re: Change in Control • November 2nd, 2004 • Quidel Corp /De/ • In vitro & in vivo diagnostic substances • California
Contract Type FiledNovember 2nd, 2004 Company Industry JurisdictionThis AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of November 8, 2004 and is entered into by and between Thomas J. Foley (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”).